Aligos Therapeutics, Inc. (ALGS) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $34.99M | -64.7% |
| 2024 | $99.07M | +66.6% |
| 2023 | $59.45M | +38.9% |
| 2022 | $42.79M | -15.5% |
| 2021 | $50.64M | +11.9% |
| 2020 | $45.26M | +54.3% |
| 2019 | $29.33M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $34.99M | -64.7% |
| 2024 | $99.07M | +66.6% |
| 2023 | $59.45M | +38.9% |
| 2022 | $42.79M | -15.5% |
| 2021 | $50.64M | +11.9% |
| 2020 | $45.26M | +54.3% |
| 2019 | $29.33M | — |